ReviewAmerican journal of hematology2012

Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Chia Chi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.